4,166
Views
17
CrossRef citations to date
0
Altmetric
Commentary

Dendritic cell-based in vitro assays for vaccine immunogenicity

&
Pages 1323-1325 | Received 28 Jun 2012, Accepted 03 Jul 2012, Published online: 01 Sep 2012

References

  • Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392:245 - 52; http://dx.doi.org/10.1038/32588; PMID: 9521319
  • Larsson K, Lindstedt M, Borrebaeck CA. Functional and transcriptional profiling of MUTZ-3, a myeloid cell line acting as a model for dendritic cells. Immunology 2006; 117:156 - 66; http://dx.doi.org/10.1111/j.1365-2567.2005.02274.x; PMID: 16423051
  • Hoefnagel MH, Vermeulen JP, Scheper RJ, Vandebriel RJ. Response of MUTZ-3 dendritic cells to the different components of the Haemophilus influenzae type B conjugate vaccine: towards an in vitro assay for vaccine immunogenicity. Vaccine 2011; 29:5114 - 21; http://dx.doi.org/10.1016/j.vaccine.2011.05.050; PMID: 21624423
  • Kim KD, Choi SC, Noh YW, Kim JW, Paik SG, Yang Y, et al. Impaired responses of leukemic dendritic cells derived from a human myeloid cell line to LPS stimulation. Exp Mol Med 2006; 38:72 - 84; PMID: 16520555
  • Rasaiyaah J, Noursadeghi M, Kellam P, Chain B. Transcriptional and functional defects of dendritic cells derived from the MUTZ-3 leukaemia line. Immunology 2009; 127:429 - 41; http://dx.doi.org/10.1111/j.1365-2567.2008.03018.x; PMID: 19538250
  • Querec T, Bennouna S, Alkan S, Laouar Y, Gorden K, Flavell R, et al. Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity. J Exp Med 2006; 203:413 - 24; http://dx.doi.org/10.1084/jem.20051720; PMID: 16461338
  • Bodewes R, Geelhoed-Mieras MM, Heldens JG, Glover J, Lambrecht BN, Fouchier RA, et al. The novel adjuvant CoVaccineHT increases the immunogenicity of cell-culture derived influenza A/H5N1 vaccine and induces the maturation of murine and human dendritic cells in vitro. Vaccine 2009; 27:6833 - 9; http://dx.doi.org/10.1016/j.vaccine.2009.09.015; PMID: 19772942
  • Giacomini E, Remoli ME, Gafa V, Pardini M, Fattorini L, Coccia EM. IFN-beta improves BCG immunogenicity by acting on DC maturation. J Leukoc Biol 2009; 85:462 - 8; http://dx.doi.org/10.1189/jlb.0908583; PMID: 19056860
  • Goriely S, Molle C, Nguyen M, Albarani V, Haddou NO, Lin R, et al. Interferon regulatory factor 3 is involved in Toll-like receptor 4 (TLR4)- and TLR3-induced IL-12p35 gene activation. Blood 2006; 107:1078 - 84; http://dx.doi.org/10.1182/blood-2005-06-2416; PMID: 16219795
  • Egger M, Jürets A, Wallner M, Briza P, Ruzek S, Hainzl S, et al. Assessing protein immunogenicity with a dendritic cell line-derived endolysosomal degradome. PLoS ONE 2011; 6:e17278; http://dx.doi.org/10.1371/journal.pone.0017278; PMID: 21359181
  • Delamarre L, Pack M, Chang H, Mellman I, Trombetta ES. Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate. Science 2005; 307:1630 - 4; http://dx.doi.org/10.1126/science.1108003; PMID: 15761154
  • Delamarre L, Couture R, Mellman I, Trombetta ES. Enhancing immunogenicity by limiting susceptibility to lysosomal proteolysis. J Exp Med 2006; 203:2049 - 55; http://dx.doi.org/10.1084/jem.20052442; PMID: 16908625
  • Jiang X, Shen C, Rey-Ladino J, Yu H, Brunham RC. Characterization of murine dendritic cell line JAWS II and primary bone marrow-derived dendritic cells in Chlamydia muridarum antigen presentation and induction of protective immunity. Infect Immun 2008; 76:2392 - 401; http://dx.doi.org/10.1128/IAI.01584-07; PMID: 18362126
  • Moser JM, Sassano ER, Leistritz C, Eatrides JM, Phogat S, Koff W, et al. Optimization of a dendritic cell-based assay for the in vitro priming of naïve human CD4+ T cells. J Immunol Methods 2010; 353:8 - 19; http://dx.doi.org/10.1016/j.jim.2009.11.006; PMID: 19925804